ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Sunesis Pharmaceuticals Inc

Sunesis Pharmaceuticals Inc (SNSS)

5.32
0.00
(0.00%)
마감 28 12월 6:00AM
0.00
0.00
(0.00%)
시간외 거래: -

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
5.32
매수가
4.72
매도가
4.75
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
market_cap
전일 종가
5.32
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
38,625,000
배당수익률
-
주가수익률
-0.12
주당순이익(EPS)
-1.32
매출
-
순이익
-51.06M

Sunesis Pharmaceuticals Inc 정보

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolo... Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-

SNSS 최신 뉴스

Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the third quarter ended September 30, 2020. Loss...

Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16th, 2020 at...

Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ...

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at the 32nd EORTC-NCI-AACR Symposium on...

Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that the Company will present at two upcoming virtual investor...

Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock Split

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it has filed a Certificate of Amendment to its Amended and...

Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the second quarter ended June 30, 2020. Loss from...

Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Hi...

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Tuesday, August 11th, 2020 at...

Sunesis Announces Pricing of $12 Million Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the pricing of an underwritten public offering of 52,173,913 shares of...

Sunesis Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it intends to offer and sell, subject to market and other...

Sunesis Pharmaceuticals Provides Corporate Update

SOUTH SAN FRANCISCO, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a reduction in workforce of approximately 30% of its head count to...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SNSS - Frequently Asked Questions (FAQ)

What is the current Sunesis Pharmaceuticals share price?
The current share price of Sunesis Pharmaceuticals is US$ 5.32
How many Sunesis Pharmaceuticals shares are in issue?
Sunesis Pharmaceuticals has 38,625,000 shares in issue
What is the market cap of Sunesis Pharmaceuticals?
The market capitalisation of Sunesis Pharmaceuticals is USD 205.49M
What is the 1 year trading range for Sunesis Pharmaceuticals share price?
Sunesis Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Sunesis Pharmaceuticals?
The price to earnings ratio of Sunesis Pharmaceuticals is -0.12
What is the reporting currency for Sunesis Pharmaceuticals?
Sunesis Pharmaceuticals reports financial results in USD
What is the latest annual profit for Sunesis Pharmaceuticals?
The latest annual profit of Sunesis Pharmaceuticals is USD -51.06M
What is the registered address of Sunesis Pharmaceuticals?
The registered address for Sunesis Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Sunesis Pharmaceuticals website address?
The website address for Sunesis Pharmaceuticals is www.viracta.com
Which industry sector does Sunesis Pharmaceuticals operate in?
Sunesis Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
INTZIntrusion Inc
US$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
131.98M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
936.47k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.31M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
926.19k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.26M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.11M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
557.72M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.75M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
298.47M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
263.01M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
250.36M

SNSS Discussion

게시물 보기
NASDAQ2020 NASDAQ2020 3 년 전
HammerTime !

GLTY SNSS-AMC
👍️0
NASDAQ2020 NASDAQ2020 4 년 전
Hammertime SNSS
👍️0
Dspetry Dspetry 4 년 전
https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-closing-of-merger-with-sunesis-pharmaceuticals-and-65m-private-placement-301234939.html
👍️0
ClayTrader ClayTrader 4 년 전
* * $SNSS Video Chart 02-24-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Jaydixson1 Jaydixson1 4 년 전
Why would anyone sell while it’s going up
👍️0
ClayTrader ClayTrader 4 년 전
* * $SNSS Video Chart 02-23-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Jaydixson1 Jaydixson1 4 년 전
Looking good
👍️0
MAKESOME79 MAKESOME79 4 년 전
$SNSS Two things are happening. 1.) #StockTrading higher after #stock upgrade from Perform to Outperform and a price target of $12 per share. 2.) Reverse Merger with @ViractaT announced the parties entered into a definitive merger agreement. This Reverse stock split. The split funny enough says 3-1 and 6-1. That means our shares are going to increase. Because a true reverse split is 1-3 or 1-6. Did you notice the difference in how it was typed. I'm thinking we will get either 3x the shares we have now of the new symbol $Virx. What are you thought on this. Second they say the have to close above 4.00 before the split. I was looking at the sec doc and was going to post the link and forgot which one it is but it is in there.
👍️0
BoilerRoom BoilerRoom 4 년 전
Guarantee it bud
👍️0
crudeoil24 crudeoil24 4 년 전
$6.00+ by closing bell. Massive volume/fomo/momo.

SNSS
👍️0
BoilerRoom BoilerRoom 4 년 전
I got in at $4.50
👍️0
crudeoil24 crudeoil24 4 년 전
I got in @ 4.11 way after opening bell.
👍️0
BoilerRoom BoilerRoom 4 년 전
$SNSS my volume scanner picked this up pre market. Easy mover
👍️0
crudeoil24 crudeoil24 4 년 전
Yup! SNSS going gangbusters!
👍️0
BoilerRoom BoilerRoom 4 년 전
$SNSS happy to get Money back here I lost on a OTC stock last week. Looking great!
👍️0
BoilerRoom BoilerRoom 4 년 전
Yes, going run today
👍️0
crudeoil24 crudeoil24 4 년 전
SNSS > 16M float > Super low trading float!
👍️0
crudeoil24 crudeoil24 4 년 전
Sunesis Pharmaceuticals shares are trading higher after Oppenheimer upgraded the stock from Perform to Outperform and announced a price target of $12 per share.

Feb 23, 2021 8:03a ETBenzinga Stock Analysis
👍️0
BoilerRoom BoilerRoom 4 년 전
$SNSS Running
👍️0
mick mick 4 년 전
Sunesis Pharmaceutic (SNSS)
3.7 ? -0.07 (-1.86%)
Volume: 261,758 @02/19/21 5:43:36 PM EST
Bid Ask Day's Range
3.62 3.9 3.65 - 3.82
SNSS Detailed Quote
👍️0
mick mick 4 년 전
https://otcbb.swingtradebot.com/equities/SNSS

N.Y. , NASDAQ
https://swingtradebot.com/equities/SNSS
👍️0
stocktalk211 stocktalk211 4 년 전
Alert From Transparent Traders

SNSS

ENTRY $3.20

STOP $2.99

TARGET $6.22


$1 30 day trial Transparent Traders Blackbox
👍️0
stocktalk211 stocktalk211 4 년 전
Alert From Transparent Traders

SNSS

ENTRY $3.20

STOP $2.99

TARGET $6.22


$1 30 day trial Transparent Traders Blackbox
👍️0
mick mick 4 년 전
https://pennystocks.news/otc/?symbol=SNSS
👍️0
mick mick 4 년 전
Sunesis Pharmaceutic (SNSS)
1.84 ? 0.05 (2.79%)
Volume: 619,300 @12/14/20 5:53:09 PM EST
Bid Ask Day's Range
1.79 1.84 1.74 - 1.88
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 년 전
SNSS Is getting on my last nerve.

When $#IT like NKLA is trading at over $17 dollars a share.
👍️0
mick mick 4 년 전
Sunesis Pharmaceutic (SNSS)
1.82 ? 0.09 (5.20%)
Volume: 1,703,641 @12/07/20 1:07:27 PM EST
Bid Ask Day's Range
1.82 1.85 1.73 - 1.91
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 년 전
SMDH

That's an acronym, not a ticker. LOL
👍️0
ClayTrader ClayTrader 4 년 전
* * $SNSS Video Chart 11-30-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
IB_ IB_ 4 년 전
She told me to sell SNSS at $2.03 and against my "hold till I'm dead nature" I listened :)

IB_
👍️0
John_Langston John_Langston 4 년 전
She F.ed you twice.
👍️0
IB_ IB_ 4 년 전
The CEO's MoM !!!!!!!!!!!!!

LoL,

IB_ :)
👍️0
John_Langston John_Langston 4 년 전
It’s 10:30 and the Looney Tunes hour is over. lol
👍️0
John_Langston John_Langston 4 년 전
NASDAQ and who else? lol
👍️0
IB_ IB_ 4 년 전
I made a few calls !!!!!!!!!!!!!!!!!!!!!!!

LoL LoL

IB_ :)
👍️0
John_Langston John_Langston 4 년 전
Well that explains everything.
👍️0
IB_ IB_ 4 년 전
I sold my SNSS today at $2.03 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

IB_ :)
👍️0
John_Langston John_Langston 4 년 전
Great news.

It’s about time.
👍️0
Techmozz Techmozz 4 년 전
https://finance.yahoo.com/news/sunesis-pharmaceuticals-viracta-therapeutics-announce-123000277.html

👍️0
mick mick 4 년 전
Sunesis Pharmaceutic (SNSS)
1.26 ? -0.04 (-3.08%)
Volume: 499,222 @11/17/20 3:44:26 PM EST
Bid Ask Day's Range
1.25 1.26 1.2 - 1.26
SNSS Detailed Quote
👍️0
mick mick 4 년 전
I DID NOT SEE IT MY FRIEND 'Sunesis Pharmaceuticals (SNSS)'
👍️0
John_Langston John_Langston 4 년 전
A great ER and the Robinhood DAs are selling.

I don't see this going up until the acquisition news is released and then the PPS will look like a Space X launch.
👍️0
John_Langston John_Langston 4 년 전
I thought Sunesis was releasing the ER today.
👍️0
mick mick 4 년 전
Sunesis Pharmaceutic (SNSS)
1.1975 ? 0.0325 (2.79%)
Volume: 305,127 @10/30/20 9:59:17 AM EDT
Bid Ask Day's Range
1.19 1.2 1.17 - 1.26
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 년 전
I added more yesterday.
👍️0
mick mick 4 년 전
Sunesis Pharmaceutic (SNSS)
1.2 ? 0.03 (2.56%)
Volume: 1,607,341 @10/29/20 6:11:48 PM EDT
Bid Ask Day's Range
1.2 1.23 1.12 - 1.24
SNSS Detailed Quote
👍️0
spacehc spacehc 4 년 전
...add ingrediency ...blend...cold down....freeze.....warm up and.........KA-BAM

Thanks to all!
👍️0
mick mick 4 년 전
Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ... GlobeNewswire Inc. - 10/12/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2020 4:14:28 PM
Sunesis Pharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire Inc. - 9/3/2020 7:00:10 AM
👍️0
mick mick 4 년 전
Sunesis Pharmaceutic (SNSS)
1.45 ? 0.15 (11.54%)
Volume: 2,006,251 @10/23/20 7:57:59 PM EDT
Bid Ask Day's Range
1.38 2.4 1.28 - 1.55
SNSS Detailed Quote
👍️0
John_Langston John_Langston 4 년 전
More like Rogersed.

The Robinhood investors buy up over one tenth of the float today at $1.45 just to sell it at $1.35 next week.

And they keep doing it week after week.

SMH
👍️0